Arcturus Therapeutics Holdings Inc. (ARCT) vs Carlsmed, Inc. (CARL)
A side-by-side comparison of Arcturus Therapeutics Holdings Inc. and Carlsmed, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARCT
Arcturus Therapeutics Holdings Inc.
$13.80HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
CARL
Carlsmed, Inc.
$15.16HealthcareDelayed quote: Oct 6, 2026, 10:09 AM EDT
Total return — ARCT vs CARL
growth of $100 · dividends reinvested · last 1yARCT -5.1% (-5.1%/yr)CARL +5.5% (+5.5%/yr)CARL compounded faster over this window
ARCT CARL
ARCT vs CARL: by the numbers
- •CARL is the larger company ($412M vs $392M market cap).
- •Both run net losses; CARL's is the smaller (-57.42% vs -391.90% net margin).
Metrics side by side
Valuation
| Metric | ARCT | CARL |
|---|---|---|
| P/S ratio | 16.48 | 6.51 |
| P/B ratio | 2.28 | 4.89 |
Profitability
| Metric | ARCT | CARL |
|---|---|---|
| Gross margin | 95.50% | 76.63% |
| Operating margin | -111.51% | -61.09% |
| Net margin | -391.90% | -57.42% |
| ROE | -54.29% | -43.14% |
| ROIC | -54.07% | -36.54% |
Growth (annualized)
| Metric | ARCT | CARL |
|---|---|---|
| Revenue CAGR (5Y) | 22.30% | N/A |
| Total return CAGR (5Y) | -18.73% | N/A |
Go deeper
Dig into the metrics
Arcturus Therapeutics ROECarlsmed ROEArcturus Therapeutics operating marginCarlsmed operating marginArcturus Therapeutics revenue growthCarlsmed revenue growthArcturus Therapeutics free cash flowCarlsmed free cash flow
Arcturus Therapeutics & Carlsmed appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.